D.E. Shaw & Co’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.87M | Buy |
53,866
+41,707
| +343% | +$2.23M | ﹤0.01% | 1717 |
|
|
2025
Q1 | $492K | Sell |
12,159
-23,650
| -66% | -$957K | ﹤0.01% | 2467 |
|
|
2024
Q4 | $996K | Sell |
35,809
-80,573
| -69% | -$2.24M | ﹤0.01% | 2120 |
|
|
2024
Q3 | $3.34M | Sell |
116,382
-199,335
| -63% | -$5.72M | ﹤0.01% | 1524 |
|
|
2024
Q2 | $7.41M | Sell |
315,717
-91,408
| -22% | -$2.14M | 0.01% | 1053 |
|
|
2024
Q1 | $10.3M | Buy |
407,125
+196,165
| +93% | +$4.96M | 0.01% | 898 |
|
|
2023
Q4 | $4.93M | Buy |
210,960
+74,062
| +54% | +$1.73M | ﹤0.01% | 1233 |
|
|
2023
Q3 | $6.92M | Sell |
136,898
-274,221
| -67% | -$13.9M | 0.01% | 1005 |
|
|
2023
Q2 | $19.2M | Buy |
411,119
+43,108
| +12% | +$2.01M | 0.02% | 577 |
|
|
2023
Q1 | $14.1M | Buy |
368,011
+74,167
| +25% | +$2.84M | 0.02% | 751 |
|
|
2022
Q4 | $16.1M | Buy |
293,844
+254,821
| +653% | +$14M | 0.02% | 699 |
|
|
2022
Q3 | $1.33M | Buy |
39,023
+28,353
| +266% | +$966K | ﹤0.01% | 2382 |
|
|
2022
Q2 | $101K | Buy |
+10,670
| New | +$101K | ﹤0.01% | 3555 |
|